Bullfrog AI Holdings, Inc. Common Stock

Day range

$0.47 – $0.50

Open

$0.49

Prev close

$0.49

Volume

116.16K

Market cap

$9.16M

Shares out

18.54M

P/E

—

P/S

30.41

P/B

1.30

P/FCF

—

ROE

-85.8%

ROA

-77.9%

Debt/Equity

0.00

Div yield

0.00%

As of Oct 23, 2026

• Listing deficiency noticeAug 20, 2026

  On February 10, 2026, BullFrog AI Holdings, Inc. received a letter from the listing staff of The Nasdaq Stock Market LLC notifying the Company that, for the then-preceding 30 consecutive business days, the closing bid price for the Company's common stock was below $1.00 per share, which is the minimum closing bid price required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5550(a)(2). The Company was provided an initial compliance period of 180 calendar days, or until August 10, 2026, to regain compliance with the Minimum Bid Price Requirement.

• Annual meeting resultsJun 15, 2026

  On June 11, 2026, the Company held its 2026 Annual Meeting of Stockholders. A total of 7,794,169 shares were present or represented by proxy at the Annual Meeting, representing approximately 42.06% of all shares entitled to vote. The four nominees listed above were elected to serve on the Board: William Enright, Jason D. Hanson, R. Donald Elsey, and Vininder Singh.

• Listing compliance regainedApr 22, 2026

  the Company received a notification letter on April 21, 2026 from the Listing Qualifications Department of the Nasdaq Stock Market notifying the Company that it had regained compliance with the minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1).

• Listing compliance regainedApr 1, 2026

  the Company has completed certain sales of its common stock under its existing at-the-market sales agreement and equity line of credit facility for aggregate net proceeds of at least $3.45 million. As a result of the foregoing transactions, as of the date of this Current Report on Form 8-K, the Company believes it now has stockholders' equity of more than $2.5 million in compliance with the Stockholders' Equity Requirement.

• Partnership or collaborationMar 30, 2026

  On March 27, 2026, BullFrog AI Holdings, Inc. (the "Company") entered into a Feasibility Agreement (the "Agreement") with a global pharmaceutical company (the "Client"). Pursuant to the Agreement, the Company will apply its proprietary methodology and artificial intelligence and machine learning tool, bfLEAP®, to discover and provide the Client with prioritized drug target candidates, associated causal gene networks with target near-neighbors unblinded, and target dossiers for advancement-ready drug candidates for major depressive disorder (MDD).

Days to cover

1.0

Short interest

739.21K

Avg volume

24.32M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine
  positiveGlobeNewswire Inc.· Mar 25, 2026
• ProFound Therapeutics Strengthens Leadership Team with Tom Chittenden as Chief Technology Officer and Laurel Ostrom as Chief Human Resources Officer
  neutralGlobeNewswire Inc.· Dec 18, 2025
• BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients
  positiveGlobeNewswire Inc.· Jun 12, 2025
• Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12
  GlobeNewswire Inc.· May 29, 2024
• BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute
  GlobeNewswire Inc.· Mar 8, 2024